Cover of: Early breast cancer | Read Online

Early breast cancer from screening to multidisciplinary management

  • 562 Want to read
  • ·
  • 82 Currently reading

Published by Harwood Academic Publishers in Amsterdam, The Netherlands .
Written in English


  • Breast -- Cancer.,
  • Breast Neoplasms -- diagnosis.,
  • Breast Neoplasms -- therapy.,
  • Mass Screening.

Book details:

Edition Notes

Includes bibliographical references and index.

Statementedited by M.W.E. Morgan, R. Warren, and G. Querci della Rovere.
ContributionsMorgan, M. W. E., Warren, R., Querci della Rovere, G.
LC ClassificationsRC280.B8 E2126 1998
The Physical Object
Pagination288 p. :
Number of Pages288
ID Numbers
Open LibraryOL3618766M
ISBN 109057024691
LC Control Number2002391908

Download Early breast cancer


Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women worldwide. 1 Although early breast cancer is a curable disease, up to 40% of such patients still relapse after surgery. 2 It is believed that breast cancer is a systemic disease and that clinically undetectable micrometastases often happened before the diagnosis. 3,4 How to . Practical, authoritative, and highly-illustrated, this volume in the brand new Early Detection and Treatment of Cancer series covers current protocols and the latest advances in diagnostic imaging and molecular and serologic markers for breast cancer. Guide for women with early breast cancer Introduction Who this book is for This book is for people who have been diagnosed with early breast cancer. It contains information to help you understand your diagnosis and treatment options. It may also be helpful for your family and friends. Everyone’s situation and needs are diff Size: 1MB. Early Breast Cancer: From Screening to Multidisciplinary Management discusses the principles and practice of breast cancer management with respect to both screen-detected and symptomatic disease. It provides readers with sound understanding and critical insight into many aspects of the disease from epidemiology, genetics, and screening to.

  Early-stage breast cancer includes stage 1, stage 2a, stage 2b and stage 3a breast cancer. In these early stages, the cancer has infected the lymph nodes that are close to the breast. The cancer has not, however, spread to other parts of the body. Health specialists will sometimes talk about noninvasive breast cancer, which refers only to stage 0 cancer. Breast cancer is a heavy topic, and the idea that cancer can come back can be daunting. That’s why we partnered with Lillie D. Shockney, former Director of the Johns Hopkins Breast Center, nurse, and two-time breast cancer survivor, to create this Recurrence eBook. The main goal of such curative surgery would be prolonged disease-free survival and improved quality of life. Provided that the breast cancer primary is controlled, there is a long disease-free period, and the patient has a good performance status, surgery is an important component in the multimodality approach to breast cancer solitary metastases. Cancer Australia’s Guide for women with early breast cancer was developed more than 5 years ago and may no longer reflect current practice. It is available for download only. Breast Cancer Network Australia (BCNA) has developed the My Journey online tool, a tailored resource to support women with breast cancer. BCNA has also produced the My Journey early breast .

Using a liquid biopsy to test for tumor cells circulating in blood, researchers found that, in women with breast cancer, the presence of these cells could identify women at risk of their cancer returning years later. TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy. Posted: June 3, Tamoxifen is effective in treating early-stage breast cancer after surgery. Some SERMs can treat advanced or metastatic breast cancer. Side effects of tamoxifen may include risk of blood clots, stroke, cataracts, endometrial and uterine cancers, bone loss in premenopausal women, mood swings, depression, and loss of libido. An overview of the evidence from nearly clinical trials in early breast cancer and conclusions that aim to help all clinicians who treat women with this disease to . Invasive breast cancer. The strongest overview was the Early Breast Cancer Trialists’ Collaborative Group (Clarke et al., ) who conducted a systematic review of individual patient data (IPD) from the relevant trials, and provided data up to the year with 15 years of follow-up.A heterogeneous group of studies were assessed of patients receiving breast conserving .